FAST NEWS: Venus Medtech’s loss narrows on surging overseas sales
The latest: Medical device maker Venus Medtech (Hangzhou) Inc. (2500.HK) reported last Thursday its net loss narrowed 31.8% last year to 721 million yuan ($99.7 million). Looking up: The company’s annual revenue…
Venus Medtech still seeking cure for governance problems
The transcatheter maker’s shares were suspended last November, and it must still meet several conditions from the Hong Kong Stock Exchange before trading can resume Key Takeways: Venus Medtech disclosed…
FAST NEWS: Venus Medtech lends to directors without required disclosure
The latest: Venus Medtech (Hangzhou) Inc. (2500.HK) said on Monday it lent about 629 million yuan ($91 million) to executive director Zi Zhenjun and Chairman Zeng Min between June 2021…
Innovex Stitches Up IPO Application with Key Device Approvals
The medical equipment maker hopes to wow investors with recent regulatory nods for two of its devices in its second filing for a Hong Kong IPOKey Takeaways:Innovex Medical has made…
MicroTech Medical Hong Kong IPO Greeted with Yawns
Diabetes device maker’s shares go largely unchanged in first four trading days despite attracting Invesco and two other mid-sized U.S. fund managers Key Takeaways: Diabetes device maker MicroTech Medical’s shares…
Medical Device Maker Venus Medtech Pumps Up Investors With Prospect of 2021 Profits
Company funds expansion through $400 million share sale as it targets U.S. and EU with growing pipeline of heart valve-replacement products Major Takeaways Venus Medtech’s recent $400 million equity fundraising…